Invention Grant
US08729021B2 PTD-UQCRB fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
有权
PTD-UQCRB融合多肽，以及含有该组合物的预防和治疗缺血性疾病的药物组合物
- Patent Title: PTD-UQCRB fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same
- Patent Title (中): PTD-UQCRB融合多肽，以及含有该组合物的预防和治疗缺血性疾病的药物组合物
-
Application No.: US13701492Application Date: 2011-06-01
-
Publication No.: US08729021B2Publication Date: 2014-05-20
- Inventor: Ho Jeong Kwon , Jung Hwa Chang
- Applicant: Ho Jeong Kwon , Jung Hwa Chang
- Applicant Address: KR Seoul
- Assignee: Industry-Academic Cooperation Foundation, Yonsei University
- Current Assignee: Industry-Academic Cooperation Foundation, Yonsei University
- Current Assignee Address: KR Seoul
- Agency: The PL Law Group, PLLC
- Priority: KR10-2010-0051892 20100601
- International Application: PCT/KR2011/004015 WO 20110601
- International Announcement: WO2011/152662 WO 20111208
- Main IPC: C07K19/00
- IPC: C07K19/00 ; A61P9/00 ; A61P9/10 ; A61P17/14 ; A61P27/02 ; A61P27/06 ; A61P13/12 ; A61P1/00 ; A61K38/17 ; A61P9/04
Abstract:
A PTD-UQCRB fusion polypeptide, and a pharmaceutical composition for preventing and treating ischemic diseases, containing the same. The PTD-UQCRB fusion polypeptide of the present invention very effectively passes through a cell membrane to induce angiogenesis and does not cause cytotoxicity, and is thus useful for preventing and treating ischemic diseases.
Public/Granted literature
Information query
